Centessa Pharmaceuticals Correlations

CNTA Stock  USD 15.75  0.09  0.57%   
The current 90-days correlation between Centessa Pharmaceuticals and Beam Therapeutics is 0.05 (i.e., Significant diversification). The correlation of Centessa Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving against Centessa Stock

  0.4DBVT DBV Technologies Earnings Call This WeekPairCorr
  0.32CGTX Cognition TherapeuticsPairCorr
  0.34SSNLF Samsung ElectronicsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
NTLACRBU
HEPACRBU
FATENTLA
NVONTLA
FATECRBU
NVOREGN
  
High negative correlations   
HEPAVERV
VERVCRBU
REGNVERV
NTLAVERV
FATEVERV
NVOVERV

Risk-Adjusted Indicators

There is a big difference between Centessa Stock performing well and Centessa Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Centessa Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BEAM  3.40  0.24  0.06  0.24  3.78 
 8.04 
 21.42 
EDIT  6.37  0.24  0.03  0.11  8.46 
 12.04 
 119.53 
CRBU  3.00 (0.63) 0.00 (1.55) 0.00 
 8.22 
 17.35 
VERV  5.44  0.78  0.15  0.28  4.82 
 11.24 
 36.90 
NTLA  3.59 (0.32) 0.00  0.54  0.00 
 7.84 
 22.98 
FATE  5.42 (0.71) 0.00 (0.31) 0.00 
 11.34 
 34.46 
REGN  1.41 (0.07) 0.00  0.13  0.00 
 2.15 
 8.14 
NVO  2.05 (0.16) 0.00  0.73  0.00 
 4.36 
 20.40 
SRPT  1.74  0.06  0.03 (0.23) 2.19 
 3.98 
 19.63 
HEPA  7.67 (1.29) 0.00 (1.46) 0.00 
 17.65 
 86.86 

Centessa Pharmaceuticals Corporate Management

Tia BushChief OfficerProfile
Ellie MDSenior OncologyProfile
MD MScEx DevelProfile
April DovholukSenior OperationsProfile
JD EsqSenior CommunicationsProfile
MBA MDPrincipal CFOProfile
David ChaoChief OfficerProfile